GSK3B and nasopharyngeal carcinoma: A recent study reported that GSK3β negatively regulates EZH2 expression in nasopharyngeal cancer cells, and the level of GSK3β phosphorylation at Ser9 is associated with higher EZH2 protein expression in patients with nasopharyngeal carcinoma [26].